期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

不同病变特征介入治疗策略选择及其并发症防治进展 被引量：1

Progress in Percutaneous Coronary Intervention Strategy Selection for Different Coronary Lesion Characteristics and Prevention of Complications
下载PDF
导出
摘要 近年来,冠心病介入治疗得到快速发展,但仍有诸多问题亟待解决。现就近年来国内外文献中关于冠状动脉介入治疗存在的问题如:复杂病变(左主干病变、慢性闭塞病变、多支血管病变、分叉病变)介入治疗策略的选择,无复流现象,支架内再狭窄,支架术后血栓等问题进行综述。 Recently,rapid developments have been made in percutaneous coronary intervention.Even so,many issues remain.This article reviews progress made in the clinical setting for coronary complex lesions,no-reflow phenomenon,intrastent restenosis,and stent related thrombosis in both Chinese and international literature.
作者 褚福永 王阶
机构地区 中国中医科学院广安门医院心内科
出处 《心血管病学进展》 CAS 2010年第5期697-700,共4页 Advances in Cardiovascular Diseases
关键词 冠心病 介入治疗 策略 支架内再狭窄 支架血栓 coronary heart disease interventional therapy strategy intrastent restenosis stent related thrombosis
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献27

  • 1刘健,丛洪良.冠心病介入治疗的进展[J].医学综述,2008,14(16):2512-2516. 被引量：14
  • 2Huang HW,Brent BN,Shaw RE.Trends in percutaneous versus surgical revascularization of unprotected left main coronary stenosis in the drug-eluting stent era:a report from the American College of Cardiology National Cardiovascular Data Registry (ACC-NCDR)[J].Catheter Cardiovasc Interv,2006,68(6):867-872.
  • 3Kappetein AP,Dawkins KD,Mohr FW,et al.Current percutaneous coronary intervention and coronary artery bypass grafting practices for three-vessel and left main coronary artery disease.Insights from the SYNTAX run-in phase[J].Eur J Cardiothorac Surg,2006,29(4):486-491.
  • 4Price MJ,Cristea E,Sawhney N,et al.Serial angiographic follow-up of sirolimus-eluting stents for unprotected left main coronary artery revascularization[J].J Am Coll Cardiol,2006,47(4):871-877.
  • 5Lee MS,Kapoor N,Jamal F,et al.Comparison of coronary artery bypass surgery with percutaneous coronary intervention with drug-eluting stents for unprotected left main coronary artery disease[J].J Am Coll Cardiol,2006,47(4):864-870.
  • 6Chieffo A,Stankovic G,Bonizzoni E,et al.Early and mid-term results of drug-eluting stent implantation in unprotected left main[J].Circulation,2005,111(6):791-795.
  • 7Chieffo A,Morici N,Maisano F,et al.Percutaneous treatment with drug eluting stent implantation versus bypass surgery for unprotected left main stenosis:a single-center experience[J].Circulation,2006,113(21):2542-2547.
  • 8Noguchi T,Miyazaki S,Morii I,et al.Percutaneous transluminal coronary angioplasty of chronic total occlusions.Determinants of primary success and long-term clinical outcome[J].Catheter Cardiovasc Interv,2000,49(3):258-264.
  • 9Suttorp MJ,Laarman GJ,Rahel BM,et al.Primary stenting of totally occluded native coronary arteriesⅡ(PRISONⅡ).A randomized comparison of bare metal stent implantation with sirolimus eluting stent implantation for the treatment of total coronary occlusions[J].Circulation,2006,114(9):921-928.
  • 10Latib A,Colombo A,Sangiorgi GM.Bifurcation stenting:current strategies and new devices[J].Heart,2009,95(6):495-504.

二级参考文献34

  • 1胡大一.美国心脏病学学会第54届年会热点荟萃[J].中华心血管病杂志,2005,33(6):582-584. 被引量：12
  • 2王效增,韩雅玲,荆全民,王守力,马颖艳,栾波,王祖禄,王冬梅.药物洗脱支架联用普通金属支架治疗多支冠状动脉病变的疗效评价[J].沈阳部队医药,2005,18(6):364-368. 被引量：1
  • 3Nath R, Amols H, Coffey C, et al. Intravascular brachytherapy physics:report of the AAPM Radiation Therapy Committee Task Group no. 60. American Association of Physicists in Medicine[ J]. Med Phys,1999,26(2) :119-152.
  • 4Naghavi M, Libby P, Falk E ,et al. From vulnerable plaque to vulnerable patient. A call for new definition and risk assessment strategies: part Ⅰ and part Ⅱ [ J ]. Circulation, 2003, 108 ( 15 ) : 1664-1778.
  • 5Falk E. Why do plaques rupture? [ J ]. Circulation, 1992,86 ( 6 Suppl) : Ⅲ30-Ⅲ42.
  • 6Bueke AP, Farb A, Malcom GT, et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly [J]. N Engl J Med,1997,336(18) :1276-1282.
  • 7Regar E, Serruys PW, Bode C, et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent(RAVEL) :sirolimus-eluting stents inhibit restenosis irrespective of the vessel size [ J ]. Circulation, 2002,106( 15 ) : 1949-1956.
  • 8Moses JW, Leon MB, Popma JJ, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery[J]. N Engl J Med,2003,349(14) :1315-1323.
  • 9Schofer J, Schluter M, Gershlick AH, et al. Sirolimus-eluting stents for treatment of patients with long atherosclerotic lesions in small coronary artery : double-blind, randomized controlled trial ( E-SIRIUS) [J]. Lancet,2003,362(4) :1093-1099.
  • 10Schampaert E, Cohen EA, Schluter M ,et al. The Canadian study of the sirolimus-eluting stent in the treatment of patients with long de novo lesions in small native coronary arteries (C-SIRIUS) [ J ]. J Am Coll Cardiol,2004,43(6) :1110-1115.

共引文献13

同被引文献14

引证文献1

二级引证文献16

心血管病学进展
2010年 第5期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部